- Home
- AIFF
as 05-16-2025 4:00pm EST
Stocks
Firefly Neuroscience Inc is an AI company developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The Company has one reportable segment: the BNA platform. The Company derives revenue from North America.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | KENMORE |
| Market Cap: | 34.4M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 1.9M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.91 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.86 - $17.20 | Next Earning Date: | 05-14-2025 |
| Revenue: | $139,000 | Revenue Growth: | -72.47% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest FIREFLY NEUROSCIENCE INC News
AIFF Breaking Stock News: Dive into AIFF Ticker-Specific Updates for Smart Investing
GlobeNewswire
14 days ago
Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.
GlobeNewswire
15 days ago
Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.
Newsfile
2 months ago
Hemostemix and FireFly Neuroscience's Brain Network Analytics (BNA(TM)) Engage to Complete Phase 1 Vascular Dementia Clinical Trial of ACP-01
GlobeNewswire
3 months ago
Firefly Neuroscience Announces Exercise of Warrants for Total Proceeds of $8.8 Million
GlobeNewswire
3 months ago
Firefly Neuroscience Accepted into NVIDIA Connect Program
GlobeNewswire
3 months ago
Firefly Neuroscience Congratulates Scientific Advisor, Dr. Christopher Wilson, Recipient of Prestigious UW Faculty of Engineering Award for Work on Superconducting Quantum Electronics
GlobeNewswire
4 months ago
Firefly Neuroscience Announces Publications Demonstrating the Utility of Advanced EEG Analytics in Drug Development and Neuropsychiatric Care
GlobeNewswire
4 months ago
Firefly Neuroscience Discovers Breakthrough Cognitive Brain Age Biomarker Using its FDA-Cleared BNA™ Platform
Compare AIFF vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AIFF FIREFLY NEUROSCIENCE INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.